cobalt(2+) 2,10,15,23-tetraaminophthalocyanine-29,30-diide (27680-31-5)

Identification
Name:	cobalt(2+) 2,10,15,23-tetraaminophthalocyanine-29,30-diide
Synonyms:	AC1L424S
CAS:	27680-31-5
Molecular Formula:	C₃₂H₂₀CoN₁₂
Molecular Weight:	631.5148
InChI:	InChI=1/C32H20N12.Co/c33-13-4-7-16-20(10-13)29-38-25(16)37-26-18-9-6-15(35)12-22(18)31(41-26)44-32-24-19(2-1-3-23(24)36)28(43-32)42-30-21-11-14(34)5-8-17(21)27(39-29)40-30;/h1-12H,33-36H2;/q-2;+2
Molecular Structure:
Properties
Safety Data

Other Product

1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
30-Noroleana-12,20(29)-dien-28-oicacid, 23-hydroxy-3-[(2-O-b-D-xylopyranosyl-a-L-arabinopyranosyl)oxy]-, (3b,4a)- (9CI)
11',29'-di-tert-butyl-5',17',23',35',38',40',43',45'-octamethyl-7',15',25',33'-tetraoxadispiro[cyclohexane-1,2'-heptacyclo[32.2.2.2~3,6~.2~16,19~.2~21,24~.1~9,13~.1~27,31~]hexatetracontane-20',1''-cyclohexane]-1'(36'),3',5',9'(44'),10',12',16',18',21',23'
fluorochromium(2+) phthalocyanine-29,31-diide
30-Noroleana-12,20(29)-dien-28-oicacid, 3-[(O-b-D-glucopyranosyl-(1®3)-O-[b-D-xylopyranosyl-(1®2)]-a-L-arabinopyranosyl)oxy]-23-hydroxy-, (3b,4a)- (9CI)
somatotropin-releasing hormone (1-30)-amide, Ala(2)-Leu(15)-Nle(27)-GABA(30)-
30-Noroleana-12,20(29)-dien-28-oicacid, 3-(a-L-arabinopyranosyloxy)-23-hydroxy-,(3b,4a)- (9CI)
Lup-20(30)-en-29-al,23-(acetyloxy)-3-oxo-, (4a)- (9CI)
11α,12α-Epoxy-3β,23-dihydroxy- 30-norolean-20(29)-en-28,13β-olide
29-(2,3-dihydroxy-2-methylpropyl)-2-hydroxy-23-(1-hydroxyethyl)-6,26-dimethyl-15-propyl-1,2,3,3a,5,6,8,9,10,15-decahydro-17H-18,9-(epiminoethanoiminoethanoiminoethanoiminomethano)pyrrolo[1',2':5,6][1,5,8,11]thiatriazacyclopentadecino[15,14-b]indole-4,7,19
29-(2,3-dihydroxy-2-methylpropyl)-15-ethyl-2-hydroxy-23-(1-hydroxyethyl)-6,26-dimethyl-1,2,3,3a,5,6,8,9,10,15-decahydro-17H-18,9-(epiminoethanoiminoethanoiminoethanoiminomethano)pyrrolo[1',2':5,6][1,5,8,11]thiatriazacyclopentadecino[15,14-b]indole-4,7,19,
Cobalt, C5-23-branched carboxylate C4-10-fatty acid complexes
Formamide,N-[11-(16-hydroxy-10-methoxy-11,21-dimethyl-12,18-dioxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,13,24,26(29),28-octaen-20-yl)-4,10-dimethoxy-3,5,9-trimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
Formamide,N-[4-(acetyloxy)-11-(16-hydroxy-22-methoxy-10,11,21-trimethyl-12,18-dioxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,13,24,26(29),28-octaen-20-yl)-10-methoxy-5,9-dimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
Formamide,N-[11-(16,22-dihydroxy-10-methoxy-11,21-dimethyl-12,18-dioxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,13,24,26(29),28-octaen-20-yl)-4,10-dimethoxy-5,9-dimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
Formamide,N-[11-(14,16-dihydroxy-10-methoxy-11,21-dimethyl-12,18-dioxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,24,26(29),28-heptaen-20-yl)-4,10-dimethoxy-5,9-dimethyl-6-oxo-1-undecen-1-yl]-N-methyl-